project id: TCGA-BRCA; case submitter id: TCGA-AQ-A1H2; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 84; days to birth: -30958; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1926; age at diagnosis: 30958; ajcc pathologic m: MX; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 475.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 156; initial weight: 210.0; oct embedded: false; preservation method: Unknown; sample id: 26b0cf7a-584f-46e5-8f83-b6b5f7d542ba; sample submitter id: TCGA-AQ-A1H2-01A; portion id: e1b3e652-94eb-4d52-a4aa-df074dd31c72; portion submitter id: TCGA-AQ-A1H2-01A-11; slide id: 529445fe-410c-43db-9fe3-e5ac13387eec; slide submitter id: TCGA-AQ-A1H2-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;